medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2014, Number 110

<< Back Next >>

Rev Enfer Infec Pediatr 2014; 27.28 (110)

HIV infection. Mucocutaneous manifestations in 63 pediatric patients

Pérez-Cantillo MF, Cortés-Peralta EC, Martínez-Herrera E, Torres-Guerrero E, Arenas-Guzmán R

Language: Spanish
References: 16
Page: 535-540
PDF size: 128.23 Kb.


ABSTRACT

Introduction: The number of HIV-infected children has raised and represents an important cause of serious illness and mortality. Dermatologic manifestations can be observed at any stage and have an important prevalence. Objective: To recognize the associated mucocutaneous manifestations in HIV and AIDS infected pediatric patients and classify them according to CD4 and viral count. Methods: A descriptive and transversal study performed at Hospice San José, Guatemala was conducted from February to March 2010. Sixty-three HIV-positive children were included. A complete physical exam and review of medical charts were made; a sample for oral mucosa swab and a sample for direct test and culture from patients with clinical suspect of onychomycosis were taken. Results:The age of the studied children varied from 1 to 17 years with an average of 7.5 years and equal distribution in both sexes. Mucocutaneous manifestations were found in 83% of the children. The most common ones were pytiriasis alba (28%), transversal leukonychia, viral warts and onychomycosis (11% each one). According to age and CD4 count, 79.63% corresponded to category 1, 16.6% to category 2 and 3.70% to category 3. Conclusions: The rise in prevalence of HIV infection in pediatric populations makes important the identifications of dermatologic diseases in this group of patients.


REFERENCES

  1. Raju K, Rao R, Ramani T, et al. Skin disease: Clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol 2005; 44: 646–649.

  2. Gatell J.M, Clotet B, et al. Guía práctica del SIDA, Clínica, Diagnóstico y Tratamiento. Masson 8ª ed. España, 2005. Pp. 499-501.

  3. Lowe S, Ferrand RA, et al. Skin disease among Human Immunodeficiency Virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection. Pediatr Infect Dis J 2010; 29(4): 346–351.

  4. Lim W, Sadick N, Gupta A, Kaplan M, Pahwa S. Skin Diseases in Children with HIV Infection and Their Association with Degree of Immunosuppression. Intl J Dermatol 1990; 29: 24-30.

  5. Ballona R, Castillo M. Manifestaciones cutáneas de Infección por VIH infantil en el Instituto de Salud del niño 1989-1997. Dermatol Perú 1998; 8 (sup.1): 23-9.

  6. Muñoz P, Gómez O y Luzoro A. Manifestaciones cutáneas de la infección por virus de inmunodeficiencia humana en niños de Santiago de Chile. Rev Chil Infect 2008; 25 (4): 277-282.

  7. Arenas, R. Micología médica ilustrada. 4 ed. México, D.F: McGraw Hill, 2011; 92-103.

  8. Carvalho V, Da Cruz C, Marinoni L, et al. Transverse leukonychia and AIDS. Arch Dis Child 2006; 91: 326.

  9. Cribier B, Mena ML. Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study. Arch Dermatol 1998; 134(10): 1216-20.

  10. Berenguer J, Laguna F, López Aldeguer J, Moreno S. Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretroviral de gran actividad. Enf Infecc Microbiol Clin 2000; 9: 457-468.

  11. Gupta AK, Taborda P. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 2000; 39(10): 746-53.

  12. Peña-Penabad C, García-Silva J. Superficial white onychomycosis in a 3 year old human immunodeficiency virus-infected child. J Eur Acad Dermatol Venereol 2001; 15(1): 51-3.

  13. Ploysangam T, Lucky AW. Childhood white superficial onychomycosis caused by Trichophyton rubrum: Report of seven cases and review of the literature. J Am Acad Dermatol 1997; 36: 29–32.

  14. Soriano Y, Tamayo L, Xochihua L, et al. Manifestaciones cutáneas en 149 pacientes pediátricos infectados con VIH-SIDA. Bol Méd Hosp Infant Méx 2001; 58: 163-7.

  15. Krcmery V, Barnesz A.J. Non- albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002: 243-260.

  16. Marón G, Gaur A, Flynn P. Antiretroviral Therapy in HIV-infected infants and children. Pediatr Infect Dis J 2010; 29: 360–363.




2020     |     www.medigraphic.com